Opening Recap
Market Pulse: Biotech and crypto storylines riled up yesterday’s session, fueling a blend of optimism and nervous energy across sectors.
Key Movers: Novo Nordisk’s oral Wegovy pill snagged FDA clearance (WABC-TV), Bitcoin’s holiday lift sparked an FOMO-driven charge (Ambcrypto.com), and Larry Ellison’s $40B media raid on CNN’s parent shook regulatory watchers (Common Dreams).
Macro & Politics: Regulators are gearing up for a showdown over media independence as the Ellison bid raises antitrust eyebrows and prompts Capitol Hill chatter.
What’s Next: Keep an eye on GLP-1 knockoff filings, tight crypto stop orders, and any subpoenas in the CNN takeover story.
Enhanced Market Commentary
Everyone’s missing that the FDA’s nod for a Wegovy pill (With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins, WABC-TV) didn’t just level up obesity treatment—it unlocked a flood of copycats. The surge in products like those detailed in Best GLP-1 Gummies for 2026: Akkermansia Probiotic Supplements for Weight Loss (GlobeNewswire) is about to fragment an already crowded market and squeeze profit margins.
Both biotech and crypto are dancing to hype over fundamentals. While Novo Nordisk riders are salivating over Wegovy’s next-gen pills, Bitcoin bulls are piling in on thin volume, setting up a bear trap as outlined in Bitcoin’s holiday rally: Are BTC bulls setting up a classic bear trap? (Ambcrypto.com). The damn speculative fever that’s driving R&D cash into GLP-1 orals is also inflating digital assets with little regard for earnings or protocol health.
Don’t get swept up—take chips off the table. Trim biotech positions before generic filings swamp the sector, and set razor-tight stops on crypto rallies. Keep an eye on the Ellison CNN bid (‘Threat to Media and Democracy’: Trump Ally Larry Ellison Puts Up $40 Billion to Help Son Buy CNN Owner, Common Dreams) for any regulatory shifts before lawmakers clamp down.
📈 Breaking Financial News
Pill was granted FDA approval this week
The Irish Times
The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment.
WABC-TV
The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment.
KFSN-TV
Wegovy pill: With FDA approval, new era of oral GLP-1 weight loss drugs beginscnn.com
CNN
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Thefly.com
Alert: The DeFi Token Set to Explode as Markets Recover Major institutions are f
This isn't speculation – this platform's role is so essential to crypto's financial system that its current price defies all logic. Just Released: The DeFi token set for massive gains as markets heat up – only $3!
🔍 Market Analysis & Insights
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Thefly.com
BRIDGEWATER, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (NASDAQ: AMRX) and mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, today announced that the U.S. Food and …
GlobeNewswire
Meesho shares fell for a third session after a blistering 110% post-IPO rally, as a low free-float, short-covering pressures and profit-taking triggered a sharp reversal. Brokerages remain constructive on the long-term growth story, even as volatility rattles…
The Times of India
Steel Bite Pro oral health supplement analyzed: ingredient research, safety data, periodontal wellness strategies, and consumer education….
GlobeNewswire
Industry analysis examines GlucoBooster and Akkermansia probiotic supplements for 2026 weight loss—ingredient research vs. clinical evidence….
GlobeNewswire
Why Are 21 Billionaires Moving Their Money ASAP?
Under the surface of the U.S. financial system… One of the biggest stock market events in 25 years is rapidly unfolding… The economist who predicted the 2008 Financial Crisis says it will be: “The Biggest Crash of Our Lifetime.” Soon your favorite tech stocks like Nvidia, Apple, Microsoft, Google , and hundreds more could come crashing down…
💰 Investment Opportunities
Could a bear trap spark Bitcoin’s holiday rally?
Ambcrypto.com
The timeframes showed bulls were in control, but how high could this rally go?
Ambcrypto.com
Oracle co-founder Larry Ellison, an ally of US President Donald Trump and one of the richest men in the world, pledged on Monday to provide $40.4 billion to help finance his son's hostile bid to acquire Warner Bros. Discovery, the owner of CNN, HBO Max, and o…
Common Dreams
Pfizer shares are trading in the mid-$20s as investors grapple with a critical question: is this battered pharmaceutical giant destined to remain stuck in neutral, or does its aggressive push into obesity drugs and oncology successes position the company for …
Rolling Out
1 Chart Reveals the Biggest ‘Tech Bubble' in History?
Thanks to a critical announcement on February 25th, we could soon witness a rapid collapse of all the biggest tech stocks in the world. Retirement accounts across the nation could get slashed by a factor of -20%, -40%, even -80%. And it all starts (and ends) with ONE single chart. The REAL cause of what is happening in our entire stock market…